EDITOR'S DESK

  • Securing Biotech Funding When Economies Get Wild

    There’s disruption on the startup biotech money trail. Navigating it requires a pliable strategy. Here, multi-time founder and investor Bert Liang shares insight on raising funds during volatile times. 

A New Cost Paradigm For CAR Cell Therapies?

Hear from Acepodia CEO Sonny Hsiao about his company's claims that its proprietary approach to conjugating novel natural killer cells could reduce the cost of cellular therapeutics.

View From Tokyo: Rise Of The “Values” Chain

The Wuhan coronavirus outbreak has brokered a virulent "value" chain debate around the world, including a global CDMO's CEO situated in Tokyo. 

The Real Threat To Biopharma Supply Chains: Bioprocessing Materials

The COVID-19 induced risk to biopharma is not a shortage of pharmaceutical ingredients. It’s the constricting supply of consumable materials and equipment necessary to produce therapies from them. Mike Piccarreta, Partner at Kearney, offers an outlook and practical advice on supply stabilization in this BioProcess Online exclusive. 

ILC Therapeutics’ Interferon Alpha 14 Joins The COVID-19 Fight

The Glasgow-based emerging biopharma recently tapped veteran biotech leader Alan Walker as CEO as it moves ahead with two therapeutic candidates, an rIFN alpha14 focused on early-stage COVID-19 infection and a tick-derived Evasin targeting late-stage COVID-19 ARDS patients.

GUEST COLUMNISTS

BIOPROCESSING WHITE PAPERS

  • Industry Trends Changing Sterile Filtration

    To help meet the needs of both large- and small-scale operations, suppliers of sterilizing-grade filters have developed new products and technologies to help meet the needs of today’s biomanufacturing processes. Industry trends toward intensified processing and increased implementation of single-use systems are changing approaches to sterile filtration and bioburden control in biomanufacturing processes.

  • What Clinical Teams Should Know About The Benefits Of Auto-Injectors

    For a host of reasons, auto-injectors are becoming biopharma companies’ delivery method of choice for commercial use and late-stage clinical trials. Auto-injectors ensure that the prescribed dose of medication is delivered fully and completely,making it easier to track compliance in clinical trials.

  • How To Reduce The Complexity Of Custom Single-Use Assemblies

    What started out as a simple bag for holding buffers or cleaning solutions has evolved to thousands of single-use products and entire processes. The industry is now calling for standardization.

  • Got Data? Using Informatics To Protect And Improve Your Business

    Life science companies are now seeing the benefits from informatics in the manufacturing side of the business. Are you ready to use data and analytics to improve decision making? There are things you can do now to get started.

  • Development Pathways For ATMPs: Virus Safety Challenges And Regulatory Perspective

    There is an increased risk of viral contamination in settings where ATMPs are prepared, making it critical to understand the contamination risks and the solutions available to control them.

BIOPROCESS ONLINE CONTENT COLLECTIONS

19_09_BPO_NextBiotechFacilityEbook_300x200

 

Designing biopharma production systems and facilities presents daily challenges, given dynamic variables like diverse processes, product frailties, space constraints, and more. This ebook covers the major aspects of the facility engineering “puzzle,” while offering some of the “how to” you’ll need to solve it.

More Content Collections

TRAINING COURSES